墨西哥城研究人员的一项新研究表明,一种广泛应用的抗痛风药可以延长肝硬变患者的存活时间。研究人员称,秋水仙碱具有显著、持久的作用。接受此药的54名患者的5年存活率(75％)是安慰剂组46名患者的一倍多。到目前为止,医生只能治疗肝硬化的症状,不能控制此病。但据墨西哥城国立SalvadorZubiran营养研究所的研究人员 A new study by researchers in Mexico City shows that a widely used anti-gout drug can prolong the survival of patients with cirrhosis. The researchers said that colchicine has a significant, long-lasting effect. The 5-year survival (75%) of 54 patients who received this drug was more than double the 46 patients in the placebo group. So far, doctors can only treat the symptoms of cirrhosis, can not control the disease. But, according to a researcher at the National Institute of Nutrition in Salvador Zubiran, Mexico City